
Millions of breast cancer patients could avoid chemotherapy thanks to a new DNA test
Scientists have developed a DNA test that can distinguish breast cancer patients who will benefit from chemotherapy from those for whom it is not necessary.
12 stories found

Scientists have developed a DNA test that can distinguish breast cancer patients who will benefit from chemotherapy from those for whom it is not necessary.

A new Bellis center has opened at Poliklinika Jih in České Budějovice, offering support and resources to women in South Bohemia who are undergoing treatment for breast cancer.
Rapid-access clinics in Ireland are struggling to assess patients with suspected breast cancer within the 10-day target, with over 11,600 patients not being seen on time last year, and one hospital reportedly only able to see about one in four patients within the target.
Lithuanian breast cancer patients forced to seek medication in Latvia or Poland LRT

A groundbreaking genomic test has shown the potential to help millions of breast cancer patients safely avoid chemotherapy. The study suggests that this test can identify patients who would not benefit from chemotherapy, offering them a chance to skip the harsh treatment.

After surgery, some breast cancer patients require additional treatment to destroy remaining local tumor cells, with decisions made individually based on the type of intervention, disease stage, and tumor characteristics.

The Think Pink Bosnia and Herzegovina organization announced it will hold a European symposium in Sarajevo titled 'Quality of Life During and After Treatment: An Integrative Approach to the Care of People with Breast Cancer'.

Findings of the study, conducted by the IIT-M and Karkinos Healthcare, along with Kumaran Hospital, Chennai, and the Chennai Breast Centre, were published in the journal BMC Cancer
A new genomic test developed by Veracyte can identify breast cancer patients who may safely forgo chemotherapy, offering a personalized treatment approach.
Researchers from Technion and an international team have developed and validated a new AI model that can predict the benefit of chemotherapy in breast cancer patients using routine pathology samples, offering a fast and accessible alternative to genomic tests.

The "Renaissance" association for breast cancer patients organized the "Day of Daffodils" in Sarajevo, a humanitarian event aimed at raising public awareness about breast cancer.
A Swedish report highlights that significantly more women, particularly breast cancer patients, receive rehabilitation compared to men who have had prostate cancer, raising concerns about equitable access to care.